Author:
Yamashita Yugo,Morimoto Takeshi,Amano Hidewo,Takase Toru,Hiramori Seiichi,Kim Kitae,Oi Maki,Akao Masaharu,Kobayashi Yohei,Toyofuku Mamoru,Izumi Toshiaki,Tada Tomohisa,Chen Po-Min,Murata Koichiro,Tsuyuki Yoshiaki,Saga Syunsuke,Nishimoto Yuji,Sasa Tomoki,Sakamoto Jiro,Kinoshita Minako,Togi Kiyonori,Mabuchi Hiroshi,Takabayashi Kensuke,Yoshikawa Yusuke,Shiomi Hiroki,Kato Takao,Makiyama Takeru,Ono Koh,Kimura Takeshi
Funder
Research Institute for Production Development, Kyoto, Japan
Mitsubishi Tanabe Pharma Corporation
Reference30 articles.
1. The epidemiology of venous thromboembolism;White;Circulation,2003
2. A.T. Cohen, G. Agnelli, F.A. Anderson, J.I. Arcelus, D. Bergqvist, J.G. Brecht, I.A. Greer, J.A. Heit, J.L. Hutchinson, A.K. Kakkar, D. Mottier, E. Oger, M.M. Samama, M. Spannagl, V.T.E.I.A.G.i. Europe, Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality, Thromb Haemost 98(4) (2007) 756–64.
3. Groshong catheter-associated subclavian venous thrombosis;Gould;Am. J. Med.,1993
4. Upper extremity thrombosis: etiology and prognosis;Demeter;Angiology,1982
5. Consequences of "conservative" conventional management of axillary vein thrombosis;Ameli;Can. J. Surg.,1987